Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder

Thapar, 2017, Neurodevelopmental disorders, Lancet Psychiatry, 4, 339, 10.1016/S2215-0366(16)30376-5 Lord, 2018, Autism spectrum disorder, Lancet, 392, 508, 10.1016/S0140-6736(18)31129-2 McPheeters, 2011, A systematic review of medical treatments for children with autism spectrum disorders, Pediatrics, 127, e1312, 10.1542/peds.2011-0427 de la Torre-Ubieta, 2016, Advancing the understanding of autism disease mechanisms through genetics, Nat Med, 22, 345, 10.1038/nm.4071 Ajram, 2017, Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder, Transl Psychiatry, 7, e1137, 10.1038/tp.2017.104 Veenstra-VanderWeele, 2017, Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, phase 2 trial, Neuropsychopharmacology, 42, 1390, 10.1038/npp.2016.237 Anagnostou, 2018, Clinical trials in autism spectrum disorder: Evidence, challenges and future directions, Curr Opin Neurol, 31, 119, 10.1097/WCO.0000000000000542 Charman, 2017, The EU-AIMS Longitudinal European Autism Project (LEAP): Clinical characterisation, Mol Autism, 8, 27, 10.1186/s13229-017-0145-9 Wang, 2013, Resting state EEG abnormalities in autism spectrum disorders, J Neurodev Disord, 5, 24, 10.1186/1866-1955-5-24 Jeste, 2015, Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders, Curr Opin Neurol, 28, 110, 10.1097/WCO.0000000000000181 Heunis, 2016, Recent advances in resting-state electroencephalography biomarkers for autism spectrum disorder-A review of methodological and clinical challenges, Pediatr Neurol, 61, 28, 10.1016/j.pediatrneurol.2016.03.010 Dickinson, 2016, Measuring neural excitation and inhibition in autism: Different approaches, different findings and different interpretations, Brain Res, 1648, 277, 10.1016/j.brainres.2016.07.011 Nelson, 2015, Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders, Neuron, 87, 684, 10.1016/j.neuron.2015.07.033 Rubenstein, 2003, Model of autism: Increased ratio of excitation/inhibition in key neural systems, Genes Brain Behav, 2, 255, 10.1034/j.1601-183X.2003.00037.x Uzunova, 2016, Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics, World J Biol Psychiatry, 17, 174, 10.3109/15622975.2015.1085597 Bruining, 2020, Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics, Sci Rep, 10, 9195, 10.1038/s41598-020-65500-4 Donoghue, 2020, Parameterizing neural power spectra into periodic and aperiodic components, Nat Neurosci, 23, 1655, 10.1038/s41593-020-00744-x Murias, 2018, Electrophysiological biomarkers predict clinical improvement in an open-label trial assessing efficacy of autologous umbilical cord blood for treatment of autism, Stem Cells Transl Med, 7, 783, 10.1002/sctm.18-0090 Roberts, 2019, A MEG study of acute Arbaclofen (STX-209) administration, Front Integr Neurosci, 13, 69, 10.3389/fnint.2019.00069 Sinclair, 2017, GABA-B agonist baclofen normalizes auditory-evoked neural oscillations and behavioral deficits in the Fmr1 knockout mouse model of fragile X syndrome, eNeuro, 4, 10.1523/ENEURO.0380-16.2017 Knociková, 2020, Nonlinear measure of EEG complexity in the Eker Rat model of autism disorder: A pilot study, 49 van Andel, 2020, Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: An open-label pilot study, Mol Autism, 11, 30, 10.1186/s13229-020-00335-4 Raz, 1987, Effects of fenfluramine on EEG and brainstem average evoked response in infantile autism. Preliminary investigation, Neuropsychobiology, 18, 105, 10.1159/000118401 Kouijzer, 2013, Is EEG-biofeedback an effective treatment in autism spectrum disorders? A randomized controlled trial, Appl Psychophysiol Biofeedback, 38, 17, 10.1007/s10484-012-9204-3 Dawson, 2012, Early behavioral intervention is associated with normalized brain activity in young children with autism, J Am Acad Child Adolesc Psychiatry, 51, 1150, 10.1016/j.jaac.2012.08.018 Sokhadze, 2012, Prefrontal neuromodulation using rTMS improves error monitoring and correction function in autism, Appl Psychophysiol Biofeedback, 37, 91, 10.1007/s10484-012-9182-5 Zhdanov, 2020, Use of machine learning for predicting escitalopram treatment outcome from electroencephalography recordings in adult patients with depression, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2019.18377 Wu, 2020, An electroencephalographic signature predicts antidepressant response in major depression, Nat Biotechnol, 38, 439, 10.1038/s41587-019-0397-3 Rajpurkar, 2020, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.6653 Ben-Ari, 2002, Excitatory actions of GABA during development: The nature of the nurture, Nat Rev Neurosci, 3, 728, 10.1038/nrn920 Ben-Ari, 2012, The GABA excitatory/inhibitory shift in brain maturation and neurological disorders, Neuroscientist, 18, 467, 10.1177/1073858412438697 Kharod, 2019, Off-label use of bumetanide for brain disorders: An overview, Front Neurosci, 13, 310, 10.3389/fnins.2019.00310 Zhang, 2020, Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios [published correction appears in Transl Psychiatry 2020;10:63], Transl Psychiatry, 10, 9, 10.1038/s41398-020-0692-2 Lemonnier, 2017, Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders, Transl Psychiatry, 7, e1124, 10.1038/tp.2017.101 Lemonnier, 2012, A randomised controlled trial of bumetanide in the treatment of autism in children, Transl Psychiatry, 2, 10.1038/tp.2012.124 Sprengers, 2021, Bumetanide for core symptoms of autism spectrum disorder (BAMBI): A single center, double-blinded, participant-randomized, placebo-controlled, phase-2 superiority trial, J Am Acad Child Adolesc Psychiatry, 60, 865, 10.1016/j.jaac.2020.07.888 Hardstone, 2012, Detrended fluctuation analysis: A scale-free view on neuronal oscillations, Front Physiol, 3, 450, 10.3389/fphys.2012.00450 Poil, 2012, Critical-state dynamics of avalanches and oscillations jointly emerge from balanced excitation/inhibition in neuronal networks, J Neurosci, 32, 9817, 10.1523/JNEUROSCI.5990-11.2012 Peng, 1995, Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series, Chaos, 5, 82, 10.1063/1.166141 Kahan, 2014, Reducing bias in open-label trials where blinded outcome assessment is not feasible: Strategies from two randomised trials, Trials, 15, 456, 10.1186/1745-6215-15-456 Thompson, 2015, Covariate adjustment had similar benefits in small and large randomized controlled trials, J Clin Epidemiol, 68, 1068, 10.1016/j.jclinepi.2014.11.001 Team, 2020 2020 Poldrack, 2020, Establishment of best practices for evidence for prediction: A review, JAMA Psychiatry, 77, 534, 10.1001/jamapsychiatry.2019.3671 Wright, 2017, ranger: A fast implementation of random forests for high dimensional data in C++ and R, J Stat Softw, 77, 1 Hadjikhani, 2018, Bumetanide for autism: More eye contact, less amygdala activation, Sci Rep, 8, 3602, 10.1038/s41598-018-21958-x Vlaskamp, 2017, Bumetanide as a candidate treatment for behavioral problems in tuberous sclerosis complex, Front Neurol, 8, 469, 10.3389/fneur.2017.00469 Bruining, 2015, Paradoxical benzodiazepine response: A rationale for bumetanide in neurodevelopmental disorders?, Pediatrics, 136, e539, 10.1542/peds.2014-4133 Puskarjov, 2014, Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures, Epilepsia, 55, 806, 10.1111/epi.12620 Ben-Ari, 2017, NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders, Trends Neurosci, 40, 536, 10.1016/j.tins.2017.07.001 Lozano-Soldevilla, 2018, On the physiological modulation and potential mechanisms underlying parieto-occipital alpha oscillations, Front Comput Neurosci, 12, 23, 10.3389/fncom.2018.00023 Lozano-Soldevilla, 2014, GABAergic modulation of visual gamma and alpha oscillations and its consequences for working memory performance, Curr Biol, 24, 2878, 10.1016/j.cub.2014.10.017 Pfeffer, 2018, Catecholamines alter the intrinsic variability of cortical population activity and perception, PLoS Biol, 16, 10.1371/journal.pbio.2003453 Avramiea, 2020, Pre-stimulus phase and amplitude regulation of phase-locked responses are maximized in the critical state, Elife, 9, 10.7554/eLife.53016 Hardan, 2019, Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies, Autism, 23, 2096, 10.1177/1362361318824103 Wink, 2018, A randomized placebo-controlled cross-over pilot study of riluzole for drug-refractory irritability in autism spectrum disorder, J Autism Dev Disord, 48, 3051, 10.1007/s10803-018-3562-5 Minshawi, 2016, A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders, Mol Autism, 7, 2, 10.1186/s13229-015-0062-8 Anagnostou, 2015, Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder, Autism, 19, 622, 10.1177/1362361314542955 Teixeira, 2014, Integrative parietal cortex processes: Neurological and psychiatric aspects, J Neurol Sci, 338, 12, 10.1016/j.jns.2013.12.025 Saxe, 2003, People thinking about thinking people. The role of the temporo-parietal junction in “theory of mind”, Neuroimage, 19, 1835, 10.1016/S1053-8119(03)00230-1 Sperdin, 2018, Early alterations of social brain networks in young children with autism, Elife, 7, 10.7554/eLife.31670 Molapour, 2021, Seven computations of the social brain, Soc Cogn Affect Neurosci, 16, 745 Fujii, 2008, Social cognition in premotor and parietal cortex, Soc Neurosci, 3, 250, 10.1080/17470910701434610 Holiga, 2019, Patients with autism spectrum disorders display reproducible functional connectivity alterations, Sci Transl Med, 11, 10.1126/scitranslmed.aat9223